Literature DB >> 30343732

Immunosuppressive Treatment for Proliferative Lupus Nephritis: Summary of a Cochrane Review.

David J Tunnicliffe1, Suetonia C Palmer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30343732     DOI： 10.1053/j.ajkd.2018.07.008

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  5 in total

Review 1.  Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.

Authors:  Thilo C von Groote; Gabrielle Williams; Eric H Au; Yizhi Chen; Anna T Mathew; Elisabeth M Hodson; David J Tunnicliffe
Journal:  Cochrane Database Syst Rev       Date:  2021-11-15

2.  Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up.

Authors:  Lorenza Maria Argolini; Giulia Frontini; Elena Elefante; Francesca Saccon; Valentina Binda; Chiara Tani; Isabella Scotti; Linda Carli; Mariele Gatto; Ciro Esposito; Maria Gerosa; Roberto Caporali; Andrea Doria; Piergiorgio Messa; Marta Mosca; Gabriella Moroni
Journal:  J Nephrol       Date:  2020-05-27       Impact factor: 3.902

3.  Effects of alternative remission criteria on outcome of pediatric proliferative lupus nephritis: a multi-center retrospective study of pediatric proliferative lupus nephritis.

Authors:  Lizhi Chen; Mei Tan; Jun Huang; Sijia Wen; Cheng Cheng; Yihao Liu; Bin Li; Wei Chen; Sui Peng; Zihua Yu; Yingjie Li; Xiaoyun Jiang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide.

Authors:  Li Zhang; Kaichong Zhang; Wei Dong; Ruizhao Li; Renwei Huang; Hong Zhang; Wanxin Shi; Shuangxin Liu; Zhuo Li; Yuanhan Chen; Zhiming Ye; Xinling Liang; Xueqing Yu
Journal:  Kidney Dis (Basel)       Date:  2020-07-28

5.  Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis.

Authors:  Yue-Peng Jiang; Xiao-Xuan Zhao; Rong-Rong Chen; Zheng-Hao Xu; Cheng-Ping Wen; Jie Yu
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.